✦ LIBER ✦

Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis

✍ Scribed by Kristen, Arnt V.; Biener, Moritz; Hegenbart, Ute; Hardt, Stefan; Schnabel, Philipp A.; Röcken, Christoph; Schonland, Stefan O.; Katus, Hugo A.; Giannitsis, Evangelos

Book ID: 126572160
Publisher: Elsevier Science
Year: 2014
Tongue: English
Weight: 232 KB
Volume: 176
Category: Article
ISSN: 0167-5273
DOI: 10.1016/j.ijcard.2014.07.106

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical utility of N-terminal pro-B-typ

Clinical utility of N-terminal pro-B-type natriuretic peptide for risk stratification of patients with acute decompensated heart failure. Derivation and validation of the ADHF/NT-proBNP risk score

✍ Scrutinio, Domenico; Ammirati, Enrico; Guida, Pietro; Passantino, Andrea; Raimon 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 542 KB

High-Sensitivity Troponin T and N-Termin

High-Sensitivity Troponin T and N-Terminal Pro-B-Type Natriuretic Peptide (NT-proBNP) and Risk of Incident Heart Failure in Patients with CKD: The Chronic Renal Insufficiency Cohort (CRIC) Study

✍ Bansal, N.; Hyre Anderson, A.; Yang, W.; Christenson, R. H.; deFilippi, C. R.; D 📂 Article 📅 2014 🏛 Lippincott Williams and Wilkins 🌐 English ⚖ 962 KB